Presented as a merger arbitrage opportunity to acquire shares of ASST at a potential discount, as SMLR trades at a very low MNAV (Market Cap to Net Asset Value) of 0.85. This is recommended for investors who are already bullish on ASST.

The company is being acquired in an all-stock deal, suggesting consolidation in a sector where valuations for Bitcoin treasury companies have been 'under strain'.

Is being acquired in an all-stock deal.

Was acquired at a 210% premium, serving as 'proof' that undervalued Bitcoin-holding companies are attractive takeover targets. This event is seen as bullish for the entire sector.

Mentioned as 'SmarterWeb', it is highlighted for its significant underperformance (down -48% in the past month) compared to MSTR.

Offers a unique opportunity to buy Bitcoin at a 6% discount to its current market price through its stock.

Could represent a value opportunity as it is trading at an 8% discount to the value of its Bitcoin holdings.

Used as a peer comparison to KULR, with the speaker arguing that the market places little value on its core medical device business, making it a less compelling 'Bitcoin treasury' stock.

An example of a 'treasury' company providing leveraged exposure to Bitcoin. These stocks typically experience a sharp pump on their BTC strategy announcement before settling at a premium to their Net Asset Value (NAV).

Highlighted as part of the positive corporate adoption trend for Bitcoin, having added $187 million worth of BTC to its treasury.